SCHEMBL5963919

SCHEMBL5963919

CCNCC1=C(c2ccccc2)C(=O)N(C)C12CCCCC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 3/20 0.34
NR1H3 Q13133 3/20 0.34
LMNA P02545 2/20 0.33
NLRP3 Q96P20 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
AKT1 P31749 1/20 0.32
AKT2 P31751 1/20 0.32
KMT2A Q03164 1/20 0.32
OPRM1 P35372 3/20 0.31
OPRD1 P41143 2/20 0.31
OPRK1 P41145 2/20 0.31
OPRL1 P41146 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5964157 0.98 SLC6A2 (0.36) NR1H2NR1H3LMNANLRP3L3MBTL1
SCHEMBL5964124 0.88 LMNA (0.33) NR1H2NR1H3LMNANLRP3L3MBTL1
SCHEMBL5963924 0.84 SMN1; SMN2 (0.39) SLC6A2SLC6A4SLC6A3KMT2AGRIN1
SCHEMBL5963908 0.82 SIGMAR1 (0.35) NR1H2NR1H3LMNASLC6A2SLC6A4
SCHEMBL5963426 0.80 SLC6A2 (0.36) NR1H2NR1H3SLC6A2SLC6A4SLC6A3
SCHEMBL5963606 0.74 LMNA (0.32) NR1H2NR1H3LMNANLRP3L3MBTL1
SCHEMBL5963932 0.73 KMT2A (0.40) LMNAKMT2AKDM4EALDH1A1PDE5A
SCHEMBL5963809 0.73 LMNA (0.36) LMNANLRP3L3MBTL1SLC6A4KMT2A
SCHEMBL5963733 0.72 PDE7A (0.41) LMNASLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL5963964 0.71 LMNA (0.31) LMNANLRP3L3MBTL1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125840-B2 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY (US) 2006-10-24 US disclosed
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues GHSR, GHRHR, SSTR4 NR1H2 3777/4885NR1H3 3696/4885LMNA 4666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.